Skip to main content
1394 search results for:

Dupilumab 

sort by |
"newest" sorts results by publication date. "most relevant" also considers factors like how often the search phrase is in the result.
  1. 01-05-2024 | Dupilumab | News

    Dupilumab

    Anaphylaxis and lack of efficacy
  2. Open Access 09-05-2024 | Online First

    Diagnostics of allergic rhinitis under dupilumab therapy

    Allergic rhinitis (AR) is a common pathological condition, affecting 20 to 30% of adults and up to 40% of children both in the United States and Europe [ 1 ]. Clinically, the disease is characterized clinically on exposure to allergen by one or …

  3. 01-04-2024 | Conjunctivitis | News

    Dupilumab/steroids/tacrolimus

    Conjunctivitis and lack of efficacy
  4. 01-04-2024 | Dupilumab | News

    Dupilumab

    No response
  5. 01-04-2024 | Dupilumab | News

    Dupilumab

    Bullous cutaneous T-cell lymphoma
  6. 01-04-2024 | Dupilumab | News

    Dupilumab/Methylprednisolone

    Osteoporosis and upper respiratory tract infection
  7. 01-04-2024 | Erythroderma | News

    Dupilumab/Tozinameran

    Vaccine failure, erythrodermic sarcoidosis with systemic involvement and lack of efficacy
  8. Open Access 06-05-2024 | Dupilumab | Online First

    The value of biomarkers in the therapy of CRSwNP with biologicals—a long-term follow-up of dupilumab therapy

    With a prevalence of 5–12%, chronic rhinosinusitis (CRS) is one of the most common chronic diseases worldwide [ 1 , 2 ]. A severe subtype of CRS is chronic rhinosinusitis with nasal polyps (CRSwNP), characterized by bilateral inflammation of the …

  9. Open Access 12-02-2024 | Dupilumab | OriginalPaper

    Switching of biological therapy to dupilumab in comorbid patients with severe asthma and CRSwNP

    Chronic rhinosinusitis with nasal polyposis (CRSwNP) represents a prevalent condition affecting approximately 1–4% of the general population, with a high impact in the quality of life (QoL) [ 1 ]. The dominant inflammation type in diffuse primary …

  10. 01-03-2024 | Dupilumab | News

    Dupilumab

    Psoriasis
  11. Open Access 02-05-2024 | Dupilumab | Online First

    Correction to: Efficacy and Safety of Dupilumab Treatment with Concomitant Topical Corticosteroids in Children Aged 6 Months to 5 Years with Severe Atopic Dermatitis

  12. 01-03-2024 | Dupilumab | News

    Dupilumab

    Parapsoriasis
  13. 01-03-2024 | Dupilumab | News

    Dupilumab

    Ulcerative colitis
  14. Open Access 13-04-2024 | Dupilumab | OriginalPaper

    Matching-Adjusted Indirect Comparison of the Efficacy at Week 32 of Tralokinumab and Dupilumab in the Treatment of Moderate-to-Severe Atopic Dermatitis

    Atopic dermatitis (AD) is a chronic, relapsing–remitting, inflammatory skin condition characterised by pruritus and eczematous lesions [ 1 , 2 ]. For adults with moderate-to-severe AD, the effect on health-related quality of life can be …

  15. 18-03-2024 | Dupilumab | Online First

    Efficacy of dupilumab in real-life settings: a STROBE study

    Chronic rhinosinusitis with nasal polyps (CRSwNP) is a condition characterized by the development of benign polyps within the nasal and sinus cavities. This debilitating chronic ailment is marked by inflammatory exacerbations and can have a …

  16. 01-02-2024 | Dupilumab | News

    Dupilumab

    Recurrent chronic eosinophilic pneumonia
  17. 29-12-2023 | Eosinophilia | OriginalPaper

    Temporal trends of blood eosinophilia in severe uncontrolled CRSwNP treated with dupilumab: a real-life study

    Dupilumab has fully entered routine clinical practice in Italy for the treatment of patients affected by severe uncontrolled chronic rhinosinusitis with nasal polyps (CRSwNP) [ 1 , 2 ]. It inhibits the signalling of Interleukin (IL)-4 and IL-13 …

  18. 01-02-2024 | Dupilumab | News

    Dupilumab/methylprednisolone

    Lumbar spine fractures and lack of efficacy
  19. 01-02-2024 | Dupilumab | News

    Dupilumab

    Sarcoidosis
  20. 01-02-2024 | Dupilumab | News

    Dupilumab/methylprednisolone

    Acute eosinophilic pneumonia and rebound effect

Filter search results

Search Operators:

„ ... ... “ Finds documents with exactly this word group, in exactly this word order and spelling (e.g., "employer branding").
AND Finds documents with both search terms (e.g., sales AND bonus).
OR Finds documents with one or the other search term (e.g., porsche OR volkswagen).
Blank Space Finds documents with all search terms. Blank space is understood as AND (e.g., man robot production).
NOT Finds documents with no appearance of the word behind NOT (e.g., ford NOT "harrison ford").
COUNT(...)>n Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g., COUNT(gear)>8).
NEAR(..., ..., ) Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g., NEAR(recruit, professionals, 20)).
* Finds documents with the search term in word versions or composites. The star * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g., lightweight*, *lightweight, *lightweight*).
? Finds documents with the search termn in different spellings."?" allows only one character (e.g., organi?ation).
& + - Special characters are understood as AND (e.g., Miller Bros. & Sons).

You can use operators in your search query to narrow down your results even more.

Tap the operator, or hover the mouse pointer over it, to read more about how it works.